Head of the department - Virus-based Therapies and Technologies
At the Fraunhofer Institute of Interfacial and Biochemical Engineering IGB, we combine biology and technology in our business areas of Health, Sustainable Chemistry, and Environmental and climate protection. We develop processes, technologies and products for patient-focused healthcare, a sustainable bio-economy as well as a climate-neutral and resource-efficient circular economy and successfully transfer new solutions into industrial implementation. We conduct research at our locations in Stuttgart, Leuna, Straubing and Biberach as well as in close collaboration with numerous universities and research in Germany and abroad. The Fraunhofer IGB is one of 76 institutes and research centers of the Fraunhofer Society (www.fraunhofer.de). Fraunhofer is the world's leading organisation for application-oriented research. Approximately 32,000 employees work on an annual research volume of 3.4 billion euros. The department of Virus-based Therapies and Technologies has two locations, the main institute in Stuttgart, and the new Virus-based Therapies branch, VBT, in Biberach. The department focuses on viral biotechnology and its enormous potential for applied research, from prokaryotic to eukaryotic viruses. The new Virus-based Therapies branch in Biberach, funded by the Baden-Württemberg Ministry of Economic Affairs, Labour and Tourism and located in the heart of the Biopharma Cluster South Germany, is dedicates to the development of biotechnological solutions for the production and analytics of viral therapeutics. It focuses on virus, cell and process technologies, in close collaboration with the local and regional partners of industrial and academic networks. The new unit acts as an interface between academia and industry with the main aim of enabling the cost-effective production of virus-based therapeutics thereby facilitating their clinical use in patients. The vacancy is aimed at people with professional experience in research and development who are interested in contributing to the successful development of the department and in working in a highly specialized environment under excellent conditions in a field with major challenges and excellent future prospects.
What you will do
Your responsibilities as head of the IGB's Virus-Based Therapies and Technologies department include
What you bring to the table
What you can expect
The weekly working time is 39 hours. The position is initially limited to 2 years. The aim is to fill the position on a permanent basis. We value and promote the diversity of our employees' skills and therefore welcome all applications - regardless of age, gender, nationality, ethnic and social origin, religion, ideology, disability, sexual orientation and identity. Severely disabled persons are given preference in the event of equal suitability. Appointment, remuneration and social security benefits based on the public-sector collective wage agreement (TVöD). Additionally Fraunhofer may grant performance-based variable remuneration components.
With its focus on developing key technologies that are vital for the future and enabling the commercial utilization of this work by business and industry, Fraunhofer plays a central role in the innovation process. As a pioneer and catalyst for groundbreaking developments and scientific excellence, Fraunhofer helps shape society now and in the future.
Interested? Apply online now. We look forward to getting to know you!
If you have any questions about the application process or the position, please contact the HR department: E-Mail: bewerbung@igb.fraunhofer.de Phone: +49 711 970 4009
Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB
Requisition Number: 78096 Application Deadline: 03/31/2025
Job Segment:
Biochemistry, Biology, Biotech, R&D Engineer, Pharmaceutical, Science, Engineering